Anders Ekblom was born on 1954. He was Board member since 2017. He is a physician, board certified in anaesthesia and intensive care, dentist and Associate Professor in physiology at the Karolinska Institute. Anders Ekblom has extensive experience from the biopharmaceutical industry globally, including being CEO and president of AstraZeneca AB Sweden. He is also Chairman of Karolinska University hospital and TFS International AB. Board member of AnaMar AB, Forska!Sverige, Infant Bacterial Therapuetics AB, Mereo Biopharma Group Ltd, Medivir AB, RSPR Pharma AB and Vetenskapsrådet.
Haematology